The Government has made available up to £8.6 billion in additional funding over the financial years 2023/24 and 2024/25, to support adult social care and discharge. This includes £1.6 billion through the Discharge Fund, to support the National Health Service and local authorities to ensure timely and effective discharge from hospital. This funding enables local authorities to buy more care packages, help people leave hospital on time, improve workforce recruitment and retention, and reduce waiting times for care.

It has not proved possible to respond to the hon. Member in the time available before Prorogation.

It has not proved possible to respond to the hon. Member in the time available before Prorogation.

It has not proved possible to respond to the hon. Member in the time available before Prorogation.

The Foreign, Commonwealth and Development Office (FCDO) annually reports on Official Development Assistance (ODA) expenditure via the Statistics on International Development publications (https://www.gov.uk/government/collections/statistics-on-international-development) and are reported in line with OECD Development and Assistance Committee sector codes.

Please note "13020" is the official OECD DAC code for both "13021" and "13022". These codes were defined and solely used by the former Department for International Development. They did not exist in the former Foreign and Commonwealth Office spend data and would not provide a complete picture for the FCDO.

Data for 2023 is not available yet.

The Foreign, Commonwealth and Development Office (FCDO) annually reports on Official Development Assistance (ODA) expenditure via the Statistics on International Development publications (https://www.gov.uk/government/collections/statistics-on-international-development). We report spend in line with OECD Development and Assistance Committee sector codes and do not readily hold spend on sexual and reproductive health and rights (SRHR), which can span across the OECD sector codes.

However, based on FCDO "Statistics on International Development: final UK aid spend 2022", and the Sexual and Reproductive Health and Rights (SRHR) spend methodology laid out in the Deutsche Stiftung Weltbevölkerung (DSW) led "Donor Delivering for SRHR" (https://donorsdelivering.report/all-editions/) we estimate the amount of UK ODA SRHR funding disbursed was £534 million or 4.68 per cent of the total Government official development assistance in 2021.

Please note these figures are not adjusted for inflation and thus are not directly comparable with the ones from the Donor Delivering for SRHR report.

The table below details the Foreign, Commonwealth and Development Office's contributions to (i) the UN Population Fund, (ii) the World Health Organisation, (iii) the UN International Children's Emergency Fund, (iv) the Joint UN Programme on HIV and AIDS, (v) the International Planned Parenthood Federation, , (vi) the Global Fund to Fight AIDS, Tuberculosis and Malaria and (vii) the UN Entity for Gender Equality and the Empowerment of Women in (A) 2021, (B) 2022. Official figures for spend in 2023 have not yet been published.

Funding for 'Women and Children First' ceased in 2016.

Note:

• The 2021 and 2022 figures are drawn from FCDO's Statistics on International Development (SID) reports. 2023 SID figures will be released in Autumn 2024.

• The UK's membership fee (Assessed contributions) for WHO is paid by Department for Health and Social care.

Individuals granted asylum have access to the labour market and to mainstream services that support their integration, including benefits and healthcare. We are working across Government to ensure these services meet the needs of all newly granted refugees.

Support is offered from Migrant Help or their partner organisation to all individuals when they receive a decision on their asylum claim. This support includes providing advice on accessing the labour market, on applying for Universal Credit and signposting to local authorities for assistance with housing.

Our commitment to NATO is unwavering. In response to Russia’s illegal war in Ukraine, we have committed almost all our forces to NATO. We contribute to every single NATO mission and declare our nuclear deterrent to NATO. We show our commitment not least through our increase in defence spending to 2.5%.

The UK remains a significant funder in the HIV response. In (i) 2021 and (ii) 2022 total bilateral expenditure for HIV and AIDS was (i) £5,831,984 and (ii) £10,035,256 respectively. Of this total Foreign Commonwealth and Development Office bilateral spend was (i) £4,548,553 and (ii) £9,916,750 for 2021 and 2022 respectively. This includes our funding to the Clinton Health Access Initiative to further improve access to essential HIV medicines and our funding to the Robert Carr Fund to support initiatives with grassroots organisations, including key populations, as part of the global HIV response.

Figures for 2023 are not yet available. They will be published in Autumn 2024.

Since the last session of Justice questions, I have met my G7 ministerial counterparts in Italy to discuss topics ranging from preventing illegal migration to tackling organised crime. Furthermore, we have announced a new offence—in which, incidentally, my G7 colleagues were very interested—prohibiting the creation of sexually explicit deepfakes, announced measures to remove parental responsibility from those convicted of the rape of a child, made progress with the Litigation Funding Agreements (Enforceability) Bill in the House of Lords to support access to justice for those such as the postmasters, and introduced an amendment to the Victims and Prisoners Bill to provide further protection for victims against unnecessary disclosure of counselling notes.

I have also attended the “Unlocking Investment in Ukraine” conference, which brought together Ukrainian lawyers and eminent British jurists. We in this country understand the importance of a strong legal sector to secure Ukraine’s future. The British people and this Parliament are determined to ensure that once it has won the war, Ukraine wins the peace as well.

National Health Service commissioned School Age Immunisation Service providers have robust catch-up plans in place for the adolescent human papillomavirus (HPV) vaccination programme based on population need, utilising opportunities from the move to one dose in September 2023.

The UK Health Security Agency (UKHSA) works closely with several charities to develop resources that can be used to raise awareness of HPV. The UKHSA also publishes annual statistics to support local NHS teams in developing plans to improve uptake and reduce inequalities for the HPV universal programme. These statistics are available at the following link:

https://www.gov.uk/government/statistics/human-papillomavirus-hpv-vaccine-coverage-estimates-in-england-2022-to-2023/human-papillomavirus-hpv-vaccination-coverage-in-adolescents-in-england-2022-to-2023#:~:text=HPV%20vaccine%20coverage%20in%20England,pandemic%20(2018%20to%202019)

NHS England has improved digital communications on vaccinations, including expanding the NHS app, and has improved access to the vaccine outside of schools through community clinics at convenient times and locations. The UKHSA also produces a number of HPV resources, which are available at the following link:

https://www.gov.uk/government/collections/hpv-vaccination-programme

Other materials are available on the UKHSA Health Publications website in a range of languages and accessible formats, which are available at the following link:

https://www.healthpublications.gov.uk/Home.html

The Government is in the process of recruiting a Chair to the Medicines and Healthcare products Regulatory Agency. The application and assessment process has concluded, and an announcement will be made when all required checks and approvals have been completed.

The process will run in accordance with the Civil Service Senior Appointments Protocol. A Civil Service Commissioner will chair this recruitment process in line with appointments of this level of seniority, and will consider the role of any incoming Chair in that process.

The Government is in the process of recruiting a Chair to the Medicines and Healthcare products Regulatory Agency. The application and assessment process has concluded, and an announcement will be made when all required checks and approvals have been completed.

The process will run in accordance with the Civil Service Senior Appointments Protocol. A Civil Service Commissioner will chair this recruitment process in line with appointments of this level of seniority, and will consider the role of any incoming Chair in that process.

The Government is in the process of recruiting a Chair to the Medicines and Healthcare products Regulatory Agency. The application and assessment process has concluded, and an announcement will be made when all required checks and approvals have been completed.

The process will run in accordance with the Civil Service Senior Appointments Protocol. A Civil Service Commissioner will chair this recruitment process in line with appointments of this level of seniority, and will consider the role of any incoming Chair in that process.

The Government is in the process of recruiting a Chair to the Medicines and Healthcare products Regulatory Agency. The application and assessment process has concluded, and an announcement will be made when all required checks and approvals have been completed.

The process will run in accordance with the Civil Service Senior Appointments Protocol. A Civil Service Commissioner will chair this recruitment process in line with appointments of this level of seniority, and will consider the role of any incoming Chair in that process.